ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF NONALCOHOLIC FATTY LIVER DISEASE IN PEOPLE WITH TYPE 2 DIABETES: FROM BENCH TO PATIENT CARE

Descargar Publicación
Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline Making Sense of the Nonalcoholic Fatty Liver Disease Clinical Practice Guidelines: What Clinicians Need to Know